MLS-101
Mineralys Therapeutics
[]
mineralys therapeutics presents positive lorundrostat results from the phase 2 target-htn trial at acc.23/wcc 
Entrepreneur & Investor. All posts are strictly my opinions. They are neither financial advice nor investment advisers. Make your own DD!